David Meeker appointed as Genzyme’s CEO

As reported by the Pharmaceutical Business Review, David Meeker has been appointed CEO of Sanofi’s subsidiary, Genzyme.

Meeker has a long history with Genzyme –

  • – 1994 – David was Medical Director at Genzyme working on the Cystic Fibrosis Gene Therapy program.
  • – He has also been the president of the Global Rare Disease Business and looked into the global launches of Aldurazyme, Fabrazyme and Myozyme.
  • – 2009 – David became the Chief Operating Officer of Genzyme

Meeker’s appointment to CEO will drive Genzyme’s push to incorporate the Rare Disease business and the Multiple Sclerosis franchise. He will join the Group Management Committee of Sanofi and report to Sanofi CEO, Christopher A. Viehbacher. Speaking of the news, Viehbacher stated,  “After working closely with David over the past six months, I am confident that he is the best person to lead Genzyme.”

Looking for a job in science? Click here to search our current science jobs now.

Posted in: Jobs, News
CK Logo in place of featured image